The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

GE Healthcare Technologies will purchase radiopharmaceutical company Sofie Biosciences to expand into a lucrative therapeutic ...

The cash deal to acquire the PET radiopharmaceuticals CMO from Trilantic North America is expected to close in H1 2027.

Oct 5 (Reuters) - Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and ...

GE HealthCare Technologies has seen its share price slide this year, which naturally pushes investors to ask whether the ...

GE HealthCare agreed to acquire SOFIE Biosciences for $945 million in cash, expanding its U.S. PET radiopharmaceutical manufacturing and distribution network and strengthening its position in the ...

GE HealthCare agreed to acquire SOFIE Biosciences for $945 million, targeting SOFIE's 21-cyclotron US manufacturing network.

Rodolphe Katra has joined from Medtronic to lead GE HealthCare’s efforts to connect devices, software and data.

Acquisition of Sofie Biosciences is second big purchase for medical imaging specialist after split from General Electric ...

Catholic Health, a New York-based healthcare system, on Thursday announced a 10-year partnership worth approximately $500M with GE HealthCare (GEHC) to modernize its operations in the areas of imaging ...

The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive ...

GE HealthCare to acquire Sofie Biosciences for $945M, expanding PET radiopharmaceutical diagnostics and PDx growth outlook.